27 results
8-K
EX-2.1
hi2via
7 Aug 23
Ikena Oncology Acquires Pionyr Immunotherapeutics in All-Stock Transaction
8:02am
8-K
EX-1.1
prmlvf0nqrh c5
15 May 23
Ikena Oncology Reports First Quarter 2023 Financial Results and Highlights Advancements Across
9:09am
S-3
EX-1.2
bt3hy1lxiqu
27 Apr 22
Shelf registration
5:17pm
DEF 14A
p9h41blb3vpp4l adr
27 Apr 22
Definitive proxy
4:32pm
10-K
ikdio8zcn4m4uxctnnp
17 Mar 22
Annual report
6:31am
10-Q
g05wba 3dslpnyy0
13 May 21
Quarterly report
4:15pm
424B4
gw9o5buxl1ivy5c
26 Mar 21
Prospectus supplement with pricing info
5:04pm
S-1/A
zkr6hsfy
22 Mar 21
IPO registration (amended)
8:51am